Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Lara Franziska Stolzenbach is a leading urologic surgeon and researcher whose work focuses on optimizing surgical outcomes for complex patient populations, particularly through the application of robot-assisted techniques. Her research centers on three key areas: the impact of patient frailty and obesity on perioperative results, the refinement of cancer staging through predictive modeling, and the management of rare prostatic tumors. Her most cited study, “Partial nephrectomy in frail patients: Benefits of robot-assisted surgery” (2021, 20 citations), demonstrates that minimally invasive approaches can significantly improve outcomes for vulnerable patients undergoing kidney-sparing surgery. She further showed, in a 2020 study (14 citations), that obesity is a critical risk factor for adverse short-term outcomes in patients receiving radical cystectomy for bladder cancer, providing essential data for preoperative counseling and risk stratification. Dr. Stolzenbach has also advanced prostate cancer care by externally validating nomograms that integrate MRI features to predict side-specific extraprostatic extension (2023, 10 citations). Additionally, her work on a solitary fibrous tumor of the prostate, managed with frozen-section supported robot-assisted nerve-sparing radical prostatectomy, highlights her expertise in treating exceedingly rare conditions. Through these contributions, Dr. Stolzenbach is shaping safer, more personalized surgical care in urologic oncology.